Welcome to our dedicated page for Cineverse SEC filings (Ticker: CNVS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cineverse Corp. (NASDAQ: CNVS) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, allowing investors to review how this next-generation entertainment studio reports on its film, streaming, and technology operations. Cineverse files periodic reports, proxy statements, and current reports that together outline its financial performance, governance practices, and material corporate events.
Among the key documents, Form 10-K annual reports and Form 10-Q quarterly reports (referenced in earnings-related 8-Ks) describe Cineverse’s revenue from streaming and digital distribution, base distribution, and content licensing, as well as information about its large content library and technology platforms such as Matchpoint™, CINESEARCH, cineCore, and C360. These filings also discuss risks, business strategy, and segment performance across its entertainment and technology activities.
Form 8-K current reports provide timely details on specific events. Recent examples include an 8-K describing an amendment to the 2017 Equity Incentive Plan approved at the November 20, 2025 annual meeting, and another 8-K outlining an employment agreement with the company’s Chief Financial Officer, including compensation and change-in-control provisions. Additional 8-Ks reference the release of quarterly and annual financial results via press releases.
The DEF 14A definitive proxy statement offers insight into Cineverse’s corporate governance, director elections, advisory votes on executive compensation, equity plan amendments, and auditor ratification. It also explains how stockholders can participate in the virtual annual meeting and vote on key proposals.
On Stock Titan, Cineverse filings are supplemented with AI-powered summaries that help explain complex sections of 10-Ks, 10-Qs, and proxies in plain language. Real-time updates from EDGAR ensure that new 8-Ks, equity plan changes, and other disclosures appear promptly, while insider-related filings such as Form 4 (when available) can be used to monitor transactions in Cineverse equity by officers and directors.
Together, these SEC documents provide a structured view of how Cineverse manages its capital, compensates executives, and reports on the progress of its entertainment and media technology businesses.
Christopher J. McGurk, CEO and Chairman of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on 10/08/2025. He acquired 263,006 restricted stock units (RSUs) that convert one-for-one into Class A common stock and now directly holds 263,006 shares from that grant. The filing also shows 103,526 Class A shares held indirectly via the Christopher and Jamie McGurk Living Trust and a reported disposition of 492,519 Class A shares. McGurk retains multiple stock appreciation rights and prior RSUs/awards: 35,000, 125,000, and 125,000 SARs at exercise prices of $29.4, $10.8, and $9.6 respectively, plus outstanding RSUs totaling 220,000 that vest on scheduled future dates. Vesting schedules for the awards are disclosed through 10/08/2028.
Insider transaction summary for Cineverse Corp. (CNVS): The reporting officer, Mark Antonio Huidor, reported a disposal and several derivative/award holdings. On 10/08/2025 he disposed of 152,561 shares of Class A common stock. Following that transaction his direct holdings include vested and unvested equity awards: a $5.8 strike stock appreciation right exercisable into 50,000 shares, and multiple restricted stock units (RSUs) and other awards totaling 382,746 Class A shares equivalent (sum of listed amounts). A newly acquired grant of 121,792 RSUs was recorded with $0 per-share price and vesting scheduled across 2026–2028. The filing shows staged vesting dates for existing awards.
Cineverse Corp. (CNVS) reported an insider equity award on a Form 4. The company’s Chief People Officer received 66,763 restricted stock units (RSUs) on 10/08/2025 (transaction code A, price $0). These RSUs vest in three equal-year tranches: 22,254 on October 8, 2026, 22,254 on October 8, 2027, and 22,255 on October 8, 2028.
Following the reported transactions, the officer beneficially owned 158,274 shares of Class A common stock directly. Derivative holdings include stock appreciation rights for 8,334 shares (exercise price $39.4, expiring 02/17/2031) and 12,500 shares (exercise price $5.8, expiring 05/16/2033), plus other RSUs of 66,667 and 76,820 with stated vesting schedules.
Erick Opeka, CSO and President of Cineverse Corp. (CNVS), reported multiple equity changes on 10/08/2025. The filing shows a disposition of 194,146 shares of Class A common stock and the acquisition/vesting of 144,147 restricted stock units into Class A common stock at no cash cost. The report lists outstanding stock appreciation rights with strike prices of $23.2, $12.8, and $5.8 covering 17,750, 60,000, and 75,000 underlying shares respectively. Several previously granted restricted stock units and appreciation rights have scheduled vesting dates between 2024 and 2028, with specific RSU tranches vesting in 2026, 2027, and 2028.
Gary S. Loffredo, Chief Legal Officer, Secretary and Senior Advisor at Cineverse Corp. (CNVS), filed a Form 4 reporting multiple equity changes on 10/08/2025. The filing shows a disposition of 170,337 shares of Class A common stock and the grant or settlement of 130,289 restricted stock units (RSUs) that were reported as acquired at $0. In addition, the filing lists existing stock appreciation rights (SARs) and RSUs totaling 203,867 underlying Class A shares across several award tranches with exercise prices of $29.4, $12.8 and $5.8 and multiple staggered vesting schedules through 2033. The document clarifies vesting timetables for legacy SARs and newly reported RSUs, indicating staged vesting dates in 2026, 2027 and 2028.
Cineverse Corp. outlines its 2017 Equity Incentive Plan governance and 2023–2025 executive and director compensation practices. The plan is administered by an independent Compensation Committee, has no evergreen replenishment, and caps aggregate director awards at 300,000 shares. Awards generally carry a minimum one-year vesting requirement (with a 5% exception), prohibit discounted options or repricings without stockholder approval, and are subject to the company's clawback policy.
Reported grants include 237,500 restricted stock awards and 237,500 restricted stock units to NEOs in fiscal 2025 (accounting for $1,501,000 of NEO CAP), and 150,000 restricted awards and 150,000 restricted units to the PEO in fiscal 2025 (accounting for $948,000 of the PEO CAP). Prior-year grants included 115,000 options in 2024 and 125,000 options in 2023 with multi-year vesting and ten-year option terms where noted. Non-employee director pay includes a $60,000 cash retainer, a $90,000 annual stock grant (trailing 20-day VWAP), committee fees, a $20,000 lead director fee, and a $180,000 new-director grant vesting over three years.
Cineverse Corp. reported that it has entered into a new employment agreement with Mark Lindsey, effective as of September 14, 2025, under which he will continue to serve as the Company’s Chief Financial Officer through a term ending September 13, 2027, with automatic one-year renewals unless timely notice is given.
The agreement provides Mr. Lindsey with an annual base salary of $350,000, a target bonus opportunity of $175,000 under the Company’s Management Annual Incentive Plan, and restricted stock units for 71,699 shares of common stock under the 2017 Equity Incentive Plan, along with participation in standard senior executive benefit plans.
Upon a termination without cause or a resignation for good reason, Mr. Lindsey is entitled to 12 months of base salary, and if such a termination occurs within two years after a change in control during the term, he would instead receive a lump-sum payment equal to two times his then-current base salary plus his target bonus for the year of termination.
Mark W. Lindsey, CFO of Cineverse Corp. (CNVS), reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 119,168 shares of Class A common stock on 09/23/2025. It also reports outstanding equity awards: a Stock Appreciation Right exercisable at $11.95 covering 20,000 underlying shares expiring 11/14/2032, and multiple Restricted Stock Units (RSUs) totaling 138,366 RSUs across different grant schedules that vest between 2025 and 2028. Specific vesting schedules are included for each award.
The company disclosed select 10-Q details for the quarter ended June 30, 2025. Its Line of Credit bears interest at 1.25% above prime, equal to 8.75% as of June 30, 2025, and matures April 8, 2028. $3.6 million was outstanding on that facility as of June 30, 2025, with $168 thousand of unamortized issuance costs recorded as other long-term assets. The company recorded a $206 thousand cost-method investment in Roundtable Securities, paid by issuing 16 thousand shares of common stock; the investment is carried at cost because ownership is under 20% and the company does not exert significant influence. No impairment charges on long-lived or finite-lived intangible assets were recorded for the three months ended June 30, 2025 and 2024. Share authorization and outstanding figures are provided for common stock and preferred series in the filing text.
Cineverse Corp. furnished an update that it has released its financial results for the three months ended June 30, 2025. The company announced these quarterly figures through a press release dated August 14, 2025, which is attached as an exhibit to the report. The earnings information in the press release and this section is designated as furnished, not filed, under securities laws, which affects how it is treated for certain liability purposes.